This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Dermagen Ab, Pergamum Ab. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taby, SE (2011)
- Täby, SE (2012 - 2013)
Company Filing History:
Years Active: 2011-2013
Title: Martin Malmsten: Innovator in Antimicrobial Peptides
Introduction
Martin Malmsten is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of antimicrobial peptides, holding a total of 3 patents. His work focuses on developing innovative solutions to combat microbial infections through the use of peptides derived from mammalian proteins.
Latest Patents
Malmsten's latest patents include groundbreaking inventions related to antimicrobial peptides with heparin binding activity. One of his notable inventions describes an antimicrobial peptide that can be derived from endogenous mammalian proteins, which are substantially free from antimicrobial activity. This peptide consists of 10 to 36 amino acid residues and includes at least four amino acid residues selected from the group consisting of K, R, and H. Additionally, he has developed pharmaceutical compositions that incorporate these antimicrobial peptides, highlighting their potential use in medical applications.
Another significant patent involves an antimicrobial peptide that comprises a first set of amino acid residues, ranging from about 2 to about 36, linked to a second set of hydrophobic amino acid residues. This invention emphasizes the peptide's antimicrobial activity, showcasing Malmsten's innovative approach to addressing microbial challenges.
Career Highlights
Throughout his career, Martin Malmsten has worked with various companies, including Dermagen AB and Pergamum AB. His experience in these organizations has allowed him to further his research and development in the field of antimicrobial peptides, contributing to advancements in healthcare and pharmaceuticals.
Collaborations
Malmsten has collaborated with notable professionals in his field, including Artur Schmidtchen and Björn Walse. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Martin Malmsten is a distinguished inventor whose work in antimicrobial peptides has the potential to revolutionize the way we combat microbial infections. His innovative patents and collaborations reflect his commitment to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile